ATE121753T1 - Octapeptid oder heptapeptidderivate, verfahren zu deren herstellung sowie medikamente, die diese verbindungen enthalten und verwendung derselben. - Google Patents
Octapeptid oder heptapeptidderivate, verfahren zu deren herstellung sowie medikamente, die diese verbindungen enthalten und verwendung derselben.Info
- Publication number
- ATE121753T1 ATE121753T1 AT92101196T AT92101196T ATE121753T1 AT E121753 T1 ATE121753 T1 AT E121753T1 AT 92101196 T AT92101196 T AT 92101196T AT 92101196 T AT92101196 T AT 92101196T AT E121753 T1 ATE121753 T1 AT E121753T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- aminobenzoyl
- aspartyl
- amino acid
- rest
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- -1 aromatic D-amino acid Chemical class 0.000 abstract 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000002237 D-aspartyl group Chemical group [H]OC(=O)[C@]([H])(N([H])[H])C([H])([H])C(*)=O 0.000 abstract 1
- 125000002716 D-tryptophyl group Chemical group N[C@@H](C(=O)*)CC1=CNC2=CC=CC=C12 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000003164 beta-aspartyl group Chemical group 0.000 abstract 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001239 threonyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU91272A HU207104B (en) | 1991-01-25 | 1991-01-25 | Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE121753T1 true ATE121753T1 (de) | 1995-05-15 |
Family
ID=10948847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92101196T ATE121753T1 (de) | 1991-01-25 | 1992-01-27 | Octapeptid oder heptapeptidderivate, verfahren zu deren herstellung sowie medikamente, die diese verbindungen enthalten und verwendung derselben. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5480870A (de) |
| EP (1) | EP0505680B1 (de) |
| JP (1) | JP2514518B2 (de) |
| KR (1) | KR920014828A (de) |
| AT (1) | ATE121753T1 (de) |
| CA (1) | CA2060034C (de) |
| DE (1) | DE69202182T2 (de) |
| ES (1) | ES2074294T3 (de) |
| FI (1) | FI105775B (de) |
| HU (1) | HU207104B (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5504069A (en) * | 1993-02-11 | 1996-04-02 | Biomeasure, Inc. | Inhibition of trauma-induced tumor growth |
| US5597894A (en) * | 1995-06-05 | 1997-01-28 | The Louisiana State University Medical Center Foundation | Multi-tyrosinated somatostatin analogs |
| IT1277391B1 (it) * | 1995-07-28 | 1997-11-10 | Romano Deghenghi | Peptidi ciclici analoghi della somatostatina ad attivita' inibitrice dell'ormone della crescita |
| US6355613B1 (en) * | 1996-07-31 | 2002-03-12 | Peptor Limited | Conformationally constrained backbone cyclized somatostatin analogs |
| WO1998008528A1 (en) | 1996-08-30 | 1998-03-05 | Biomeasure Incorporated | Method of inhibiting fibrosis with a somatostatin agonist |
| WO1998051330A1 (en) | 1997-05-13 | 1998-11-19 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) | Method and compositions for treating hyperlipidemia and other conditions |
| US6004928A (en) * | 1997-05-13 | 1999-12-21 | Biomeasure, Incorporated | Method of treating hyperlipidemia |
| AU7655098A (en) | 1997-05-13 | 1998-12-08 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Somatostatin and somatostatin agonists for decreasing body weight |
| HU226567B1 (en) * | 1998-04-27 | 2009-04-28 | Biostatin Gyogyszerkutato Fejl | Use of phenylhydrazon derivates for the preparation of medicaments for the inhibition of neurogenic and non-neurogenic inflammations and for the alleviation of pain |
| US5968903A (en) * | 1998-05-07 | 1999-10-19 | Biomeasure, Incorporated | Inhibition of H. pylori proliferation |
| AU9436298A (en) * | 1998-08-20 | 2000-03-14 | Orpegen Pharma Gesellschaft Fur Biotechnologische Forschung, Entwicklung Und Produktion MBH | Method for producing biostatin (tt-232 triacetate) and the analogs thereof |
| CA2376506C (en) * | 1999-06-04 | 2014-07-22 | Dean Sadat-Aalaee | Neuromedin b and somatostatin receptor agonists |
| CN1367792A (zh) * | 1999-06-25 | 2002-09-04 | 研究及应用科学协会股份有限公司 | 促生长素抑制素激动剂 |
| US6864234B1 (en) | 1999-06-25 | 2005-03-08 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Somatostatin agonists |
| BR0210915A (pt) | 2001-06-08 | 2004-06-08 | Sod Conseils Rech Applic | Análogos quiméricos de somatostatina-dopamina |
| US6987167B2 (en) * | 2002-05-22 | 2006-01-17 | Wockhardt Limited | Process for production of the somatostatin analog, octreotide |
| CN101791409A (zh) | 2003-04-22 | 2010-08-04 | 研究及应用科学协会股份有限公司 | 肽载体 |
| US7842662B2 (en) | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
| US8236766B2 (en) | 2006-11-10 | 2012-08-07 | Cara Therapeutics, Inc. | Uses of synthetic peptide amides |
| US7713937B2 (en) | 2006-11-10 | 2010-05-11 | Cara Therapeutics, Inc. | Synthetic peptide amides and dimeric forms thereof |
| RU2500685C2 (ru) | 2006-11-10 | 2013-12-10 | Кара Терапеутикс, Инк | Синтетические пептидные амиды |
| US8906859B2 (en) | 2006-11-10 | 2014-12-09 | Cera Therapeutics, Inc. | Uses of kappa opioid synthetic peptide amides |
| CA2727082C (en) | 2008-06-12 | 2019-02-26 | Syntaxin Limited | Fusion proteins for use in suppression of acromegaly |
| CN102083451A (zh) | 2008-06-12 | 2011-06-01 | 赛恩泰新公司 | 癌症的抑制 |
| GB0820970D0 (en) | 2008-11-17 | 2008-12-24 | Syntaxin Ltd | Suppression of cancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4725577A (en) * | 1985-04-25 | 1988-02-16 | Administrators Of The Tulane Educational Fund | Biologically active lysine containing octapeptides |
| US4650787A (en) * | 1985-04-25 | 1987-03-17 | Schally Andrew Victor | Biologically active octapeptides |
| JPH085913B2 (ja) * | 1985-09-12 | 1996-01-24 | ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド | 治療用ソマトスタチン同族体 |
| JP2568228B2 (ja) * | 1987-02-03 | 1996-12-25 | ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド | 治療用ソマトスタチンアナログ |
| JP2809403B2 (ja) * | 1987-07-07 | 1998-10-08 | ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド | 治療用ソマトスタチンアナログ化合物 |
| CA2012115C (en) * | 1989-03-15 | 2001-07-03 | Biomeasure, Inc. | Iodinated somatostatins |
| WO1991009056A1 (en) * | 1989-12-08 | 1991-06-27 | The Administrators Of The Tulane Educational Fund | Octapeptide analogs of somatostatin having threonine at the sixth position |
-
1991
- 1991-01-25 HU HU91272A patent/HU207104B/hu not_active IP Right Cessation
-
1992
- 1992-01-22 KR KR1019920000840A patent/KR920014828A/ko not_active Withdrawn
- 1992-01-24 FI FI920340A patent/FI105775B/fi active
- 1992-01-24 CA CA002060034A patent/CA2060034C/en not_active Expired - Lifetime
- 1992-01-27 JP JP4033920A patent/JP2514518B2/ja not_active Expired - Fee Related
- 1992-01-27 AT AT92101196T patent/ATE121753T1/de not_active IP Right Cessation
- 1992-01-27 EP EP92101196A patent/EP0505680B1/de not_active Expired - Lifetime
- 1992-01-27 DE DE69202182T patent/DE69202182T2/de not_active Expired - Fee Related
- 1992-01-27 ES ES92101196T patent/ES2074294T3/es not_active Expired - Lifetime
-
1994
- 1994-04-26 US US08/233,558 patent/US5480870A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FI105775B (fi) | 2000-10-13 |
| EP0505680A1 (de) | 1992-09-30 |
| JPH05163299A (ja) | 1993-06-29 |
| DE69202182D1 (de) | 1995-06-01 |
| KR920014828A (ko) | 1992-08-25 |
| JP2514518B2 (ja) | 1996-07-10 |
| FI920340A7 (fi) | 1992-07-26 |
| CA2060034C (en) | 2002-10-29 |
| HU207104B (en) | 1993-03-01 |
| HU910272D0 (en) | 1991-08-28 |
| CA2060034A1 (en) | 1992-07-26 |
| ES2074294T3 (es) | 1995-09-01 |
| HUT60752A (en) | 1992-10-28 |
| EP0505680B1 (de) | 1995-04-26 |
| US5480870A (en) | 1996-01-02 |
| FI920340A0 (fi) | 1992-01-24 |
| DE69202182T2 (de) | 1995-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE121753T1 (de) | Octapeptid oder heptapeptidderivate, verfahren zu deren herstellung sowie medikamente, die diese verbindungen enthalten und verwendung derselben. | |
| ATE214055T1 (de) | Retinoid-potenzierende verbindungen | |
| ATE132156T1 (de) | Latente carbamat-silizium-haftvermittler und verfahren zu deren herstellung und verwendung | |
| ATE190305T1 (de) | Aryl(alkyl)propylamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten | |
| DE69205327D1 (de) | Harnstoffderivate, Verfahren zu ihrer Herstellung und diese enthaltende Medikamente. | |
| ATE218576T1 (de) | Phosphohalohydrine, verfahren zu deren herstellung und verwendungen | |
| DE69430636D1 (de) | Neue imidazol-derivate und verfahren zu deren herstellung | |
| ATE113033T1 (de) | Aminosäurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| MX9706394A (es) | Compuestos de 1-aril-2-acilamino-etano y su uso como antagonistas de neuroquinina, especialmente neuroquinina-1. | |
| EP1156031A4 (de) | Verbindungen, aus der verbindung hergestelltes polymer und das polymer enthaltende mischung | |
| ATE160338T1 (de) | Alpha aminosäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| IS3828A (is) | Hliðstæð aðferð til tilreiðslu á nýjum afleiðum thiazolidinone og oxazolidinone sem gagnlegar eru til æðaútvíkkunar | |
| ATE211137T1 (de) | Substituierte benzylthienylpiperazine, ihre anwendung als arzneimittel und verfahren für ihre herstellung | |
| ATE172956T1 (de) | Fluorenonderivate, verfahren zu ihrer herstellung sowie wiederherstellungs- und schutzmittel für zentrale und periphere nervendegenerationen | |
| ATE159521T1 (de) | Thioacylierungsmittel und zwischenprodukte, thiopeptide, und verfahren zu deren herstellung und anwendung | |
| DE59902734D1 (de) | Verfahren zur Oxidation von Methyl-, Methylen- oder Methingruppen enthaltenden Substraten | |
| TW288013B (de) | ||
| DE69224613D1 (de) | Peptide, Herstellung und deren Verwendung | |
| ATE170520T1 (de) | Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| DE69721055D1 (de) | Verfahren zur herstellung von depsipeptiden und zwischenprodukten davon | |
| ATE281452T1 (de) | 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
| ATE143957T1 (de) | Aminoalkylchomone, verfahren für ihre herstellung und die enthaltende pharmazeutische zusammensetzungen | |
| ATE165082T1 (de) | Bisquartäre ammoniumverbindungen des 2,2'- dimethyl-1,1'-binaphtyls und verfahren zu deren herstellung | |
| ATE11770T1 (de) | N,n,disubstituierte alkenamide und phenylaldenamide, verfahren zu deren herstellung und deren verwendung als pharmazeutika. | |
| ATE149997T1 (de) | 1-phenybicyclo-2,2,2-oktanderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |